HS III PROXIMAL SEAL SYTEM 3.8MM
Report
- Report Number
- 2242352-2013-00626
- Event Type
- Malfunction
- Date Received
- June 25, 2013
- Date of Event
- June 5, 2013
- Report Date
- June 7, 2013
- Manufacturer
- MAQUET CARDIOVASCULAR,LLC
- Product Code
- DXC
- PMA / PMN Number
- K080169
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE WAS RETURNED TO THE FACTORY FOR EVALUATION. IT SHOWED NO SIGNS OF CLINICAL USAGE OR EVIDENCE OF BLOOD. THE DELIVERY DEVICE WAS RETURNED OUTSIDE THE LOADING DEVICE. THE TENSION SPRING ASSEMBLY, ANCHOR TAB AND SEAL WERE INSIDE THE LOADING DEVICE. THE GREEN SLIDE LOCK AND THE WHITE PLUNGER WERE DEPRESSED ON THE DELIVERY DEVICE. THIS FAILURE IS POTENTIALLY ATTRIBUTED TO USER TECHNIQUE. IT APPEARS THAT THE SEAL HAD BEEN PREMATURELY DEPLOYED IN THE LOADING DEVICE. AS STATED IN THE IFU, THE USE SHOULD ENSURE THAT THE LOCK IS LOCKED. IF THE LOCK IS UNLOCKED, CARE SHOULD BE TAKEN TO AVOID ANY ACCIDENTAL DEPRESSING OF THE PLUNGER. BASED UPON THE EVALUATION RESULTS, THE REPORTED COMPLAINT COULD NOT BE CONFIRMED; HOWEVER IT WAS CONFIRMED FOR PREMATURE DEPLOYMENT. A LOT HISTORY RECORD REVIEW WAS COMPLETED FOR THE REPORTED PRODUCT LOT NUMBER. THERE WAS NO NONCONFORMANCE RECORDED IN THE LOT HISTORY. THE CUSTOMER HAS BEEN ADVISED OF OUR EVALUATION RESULTS, AS WELL AS THE RELEVANT SECTION OF THE IFU. INTERNAL FILE NUMBER - (B)(4).
THE HOSPITAL REPORTED THAT DURING A CORONARY ARTERY BYPASS PROCEDURE, THE HEARTSTRING III FAILED TO LOAD PROPERLY. THE SEAL DID NOT FOLD PROPERLY IN THE LOADER. A REPLACEMENT DEVICE WAS USED TO COMPLETE THE PROCEDURE. THE HOSPITAL DID NOT REPORT ANY PATIENT EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 288092 | HS III PROXIMAL SEAL SYTEM 3.8MM | CLAMPLESS BEATING HEART | DXC | MAQUET CARDIOVASCULAR,LLC | HSK-3038 | 25063053 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA |